TissGeneSummary for CNTN2 |
Gene summary |
Basic gene information | Gene symbol | CNTN2 |
Gene name | contactin 2 (axonal) | |
Synonyms | AXT|FAME5|TAG-1|TAX|TAX1 | |
Cytomap | UCSC genome browser: 1q32.1 | |
Type of gene | protein-coding | |
RefGenes | NM_005076.3, | |
Description | axonal glycoprotein TAG-1axonin-1 cell adhesion moleculecontactin 2 (transiently expressed)contactin-2transient axonal glycoprotein 1transiently-expressed axonal glycoprotein | |
Modification date | 20141207 | |
dbXrefs | MIM : 190197 | |
HGNC : HGNC | ||
Ensembl : ENSG00000184144 | ||
HPRD : 01826 | ||
Vega : OTTHUMG00000037105 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CNTN2 | |
BioGPS: 6900 | ||
Pathway | NCI Pathway Interaction Database: CNTN2 | |
KEGG: CNTN2 | ||
REACTOME: CNTN2 | ||
Pathway Commons: CNTN2 | ||
Context | iHOP: CNTN2 | |
ligand binding site mutation search in PubMed: CNTN2 | ||
UCL Cancer Institute: CNTN2 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,TiGER | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Brain | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | GBM,LGG | |
Reference showing the relevant tissue of CNTN2 | ||
Description by TissGene annotations | Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for CNTN2 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
HNSC | -2.148492943 | -0.721232478 | -1.427260465 | 1.19E-06 | 8.93E-06 |
BRCA | -0.641633661 | 0.602964585 | -1.244598246 | 1.49E-10 | 5.78E-10 |
PRAD | -0.698941691 | 0.342537156 | -1.041478846 | 6.46E-06 | 3.83E-05 |
COAD | -1.893537844 | 2.283581386 | -4.177119231 | 5.98E-15 | 3.28E-13 |
KICH | -2.742142152 | -1.122410152 | -1.619732 | 5.93E-07 | 2.32E-06 |
LUSC | -1.08009878 | -2.179732113 | 1.099633333 | 0.00902 | 0.014467977 |
BLCA | -1.834288047 | 0.783238269 | -2.617526316 | 0.000168 | 0.001653239 |
STAD | -1.072617652 | 1.145707348 | -2.218325 | 8.80E-05 | 0.000689589 |
Top |
TissGene-miRNA for CNTN2 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CNTN2 |
TissGeneSNV for CNTN2 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.W921* | SKCM | 1 |
p.G988R | LUAD | 1 |
p.S718G | LIHC | 1 |
p.E365G | LIHC | 1 |
p.R506X | STAD | 1 |
p.E374V | PCPG | 1 |
p.R1016C | GBM | 1 |
p.A873V | SKCM | 1 |
p.R359C | COAD | 1 |
p.T676N | LUAD | 1 |
p.W544* | PAAD | 1 |
p.V888M | COAD | 1 |
p.P289A | LGG | 1 |
p.R813M | LUAD | 1 |
p.N343S | SKCM | 1 |
p.D618V | BLCA | 1 |
p.R736W | LUAD | 1 |
p.G855E | SKCM | 1 |
p.R793C | SKCM | 1 |
p.R789C | HNSC | 1 |
p.V1024D | SARC | 1 |
p.E809K | BLCA | 1 |
p.E828K | SKCM | 1 |
p.E134K | SKCM | 1 |
p.G743V | STAD | 1 |
p.Q326* | BRCA | 1 |
p.V1001L | BRCA | 1 |
p.D954V | COAD | 1 |
p.T210P | BRCA | 1 |
p.R274H | STAD | 1 |
p.G364R | STAD | 1 |
p.I690M | LIHC | 1 |
p.A159V | HNSC | 1 |
p.M538I | SKCM | 1 |
p.V729I | HNSC | 1 |
p.E55K | SKCM | 1 |
p.R1016C | LGG | 1 |
p.W852L | LIHC | 1 |
p.I569N | LUSC | 1 |
p.E975K | STAD | 1 |
p.A406V | UCS | 1 |
p.M80I | SKCM | 1 |
p.R1016C | COAD | 1 |
p.V604D | KIRC | 1 |
p.A577T | HNSC | 1 |
p.W852C | BLCA | 1 |
p.P637L | ESCA | 1 |
p.F135L | UCEC | 1 |
p.R64Q | SKCM | 1 |
p.W628* | LUAD | 1 |
p.S407C | HNSC | 1 |
p.W653R | LUAD | 1 |
p.A713T | THYM | 1 |
p.E799K | STAD | 1 |
p.G265E | SKCM | 1 |
p.G612R | SKCM | 1 |
p.R793H | STAD | 1 |
p.R893P | STAD | 1 |
p.G391S | UCEC | 1 |
p.R793C | STAD | 1 |
p.D535N | COAD | 1 |
p.D470H | KIRP | 1 |
p.G716R | SKCM | 1 |
p.L170H | LUAD | 1 |
p.V412M | SARC | 1 |
p.R657W | SKCM | 1 |
p.I436N | STAD | 1 |
p.L950P | LUAD | 1 |
p.P366L | COAD | 1 |
p.S206F | SKCM | 1 |
p.A351G | COAD | 1 |
p.R6K | SKCM | 1 |
p.D618N | BLCA | 1 |
p.D535N | SKCM | 1 |
p.T591M | STAD | 1 |
p.P43L | LIHC | 1 |
p.W921X | SKCM | 1 |
p.D339N | LUAD | 1 |
p.E138K | SKCM | 1 |
p.V819A | LIHC | 1 |
p.R1002K | SKCM | 1 |
p.A899V | KICH | 1 |
p.W758R | ACC | 1 |
p.E124K | SKCM | 1 |
p.A63V | LUAD | 1 |
p.R140Q | HNSC | 1 |
p.P972T | LUAD | 1 |
p.T676N | BLCA | 1 |
p.E785K | HNSC | 1 |
p.S479N | STAD | 1 |
p.L437V | DLBC | 1 |
p.R432G | BLCA | 1 |
p.G990R | SKCM | 1 |
p.D954N | BLCA | 1 |
p.E483* | UCEC | 1 |
p.P469L | ESCA | 1 |
p.V729I | STAD | 1 |
p.V805L | LUAD | 1 |
p.T316I | SKCM | 1 |
p.L153F | COAD | 1 |
p.W544X | PAAD | 1 |
p.E776K | SKCM | 1 |
p.L603M | UCEC | 1 |
p.P699S | UCEC | 1 |
p.S334W | BRCA | 1 |
p.D389N | BLCA | 1 |
p.G965D | HNSC | 1 |
p.Q394* | LUAD | 1 |
p.V151L | CHOL | 1 |
p.Y781N | LUAD | 1 |
p.E79V | CHOL | 1 |
p.G181R | SARC | 1 |
p.R762Q | HNSC | 1 |
p.E975K | CESC | 1 |
p.G582W | ESCA | 1 |
p.W25* | SKCM | 1 |
p.R506Q | SKCM | 1 |
p.E599K | SKCM | 1 |
p.G990R | UCEC | 1 |
p.G319D | BLCA | 1 |
p.V412M | LUAD | 1 |
p.R684W | UVM | 1 |
p.S1028F | SKCM | 1 |
p.E858K | SKCM | 1 |
p.V424M | COAD | 1 |
p.P442H | LUAD | 1 |
p.G118C | PRAD | 1 |
p.A408T | STAD | 1 |
p.E457X | COAD | 1 |
p.R704Q | COAD | 1 |
p.G877D | UCEC | 1 |
Top |
TissGeneCNV for CNTN2 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CNTN2 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BP362529 | MAT2A-CNTN2 | chr2:85770157 | chr1:205036226 | |
Chimerdb3.0 | ChiTaRs | NA | W25115 | C10orf137-CNTN2 | chr10:127441464 | chr1:205013685 |
Top |
TissGeneNet for CNTN2 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CNTN2 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CNTN2 |
TissGeneDrug for CNTN2 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CNTN2 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0023493 | Adult T-Cell Lymphoma/Leukemia | 77 | BeFree,LHGDN |
umls:C0023492 | Leukemia, T-Cell | 21 | BeFree |
umls:C0030481 | Tropical Spastic Paraparesis | 8 | BeFree |
umls:C0598766 | Leukemogenesis | 5 | BeFree |
umls:C0023418 | leukemia | 4 | BeFree |
umls:C0393819 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 4 | BeFree,GAD |
umls:C0596263 | Carcinogenesis | 4 | BeFree |
umls:C1512326 | Human T-cell lymphotropic virus 1 infection | 4 | BeFree |
umls:C0019693 | HIV Infections | 3 | BeFree |
umls:C0003864 | Arthritis | 2 | BeFree |
umls:C0003873 | Rheumatoid Arthritis | 2 | BeFree |
umls:C0028945 | oligodendroglioma | 2 | BeFree |
umls:C0375019 | Human T-cell lymphotrophic virus, type I [HTLV-I] | 2 | BeFree |
umls:C0555198 | Malignant Glioma | 2 | BeFree |
umls:C0751396 | Well Differentiated Oligodendroglioma | 2 | BeFree |
umls:C0004114 | Astrocytoma | 1 | BeFree |
umls:C0005956 | Bone Marrow Diseases | 1 | BeFree |
umls:C0014544 | Epilepsy | 1 | BeFree |
umls:C0015644 | Muscular fasciculation | 1 | BeFree |
umls:C0017636 | Glioblastoma | 1 | BeFree |
umls:C0017638 | Glioma | 1 | BeFree |
umls:C0020097 | HTLV-I Infections | 1 | BeFree |
umls:C0022408 | Arthropathy | 1 | BeFree |
umls:C0024314 | Lymphoproliferative Disorders | 1 | BeFree |
umls:C0025202 | melanoma | 1 | BeFree |
umls:C0025958 | Microcephaly | 1 | BeFree |
umls:C0029925 | Ovarian Carcinoma | 1 | BeFree |
umls:C0036572 | Seizures | 1 | BeFree |
umls:C0037928 | Spinal Cord Diseases | 1 | BeFree |
umls:C0040100 | Thymoma | 1 | BeFree |
umls:C0040822 | Tremor | 1 | BeFree |
umls:C0079731 | B-Cell Lymphomas | 1 | BeFree |
umls:C0085110 | Severe Combined Immunodeficiency | 1 | BeFree |
umls:C0085655 | Polymyositis | 1 | BeFree |
umls:C0086981 | Sicca Syndrome | 1 | BeFree |
umls:C0162678 | Neurofibromatoses | 1 | BeFree |
umls:C0175697 | Van der Woude syndrome | 1 | BeFree |
umls:C0242338 | HTLV Infections | 1 | BeFree |
umls:C0263680 | Chronic arthritis | 1 | BeFree |
umls:C0334590 | Anaplastic Oligodendroglioma | 1 | BeFree |
umls:C0338656 | Impaired cognition | 1 | BeFree |
umls:C1140680 | Malignant neoplasm of ovary | 1 | BeFree |
umls:C1516170 | Cancer Cell Growth | 1 | BeFree |
umls:C1518296 | Neuropathogenesis | 1 | BeFree |
umls:C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 1 | BeFree |
umls:C1621958 | Glioblastoma Multiforme | 1 | BeFree |
umls:C3809374 | EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5 | 0 | CLINVAR |